文献速递新发突发、热带与寄生虫病

青蒿素部分耐药处于十字路口:恶性疟原虫清除表型存在洲际差异的证据

Artemisinin partial resistance at a crossroads: evidence for continental variation in Plasmodium falciparum clearance phenotypes.
PubMed 文献 · Lancet Infect Dis · 2026-05-07

本文系统综述了东南亚和非洲共96项研究,其中35项报告了基因型相关的原虫清除半衰期或环期存活率数据。研究发现东南亚k13突变虫株清除半衰期延长且与RSA一致,而东非和非洲之角独立出现的k13突变虫株清除更快但RSA存活率升高,提示现行基于东南亚的清除半衰期阈值可能低估非洲青蒿素部分耐药。

要点

  • 东南亚k13突变虫株清除半衰期延长,与RSA高度一致。
  • 东非和非洲之角k13突变虫株清除更快但RSA存活率升高。
  • 现行清除半衰期阈值可能掩盖非洲青蒿素部分耐药早期信号。

核心结论

  • 东南亚与非洲的恶性疟原虫清除表型存在洲际差异,现行基于东南亚的清除半衰期阈值可能不适用于非洲。

研究设计与样本

  • 系统综述纳入东南亚和非洲共96项研究,其中35项报告了基因型相关的原虫清除半衰期或环期存活率数据或两者兼有。

主要发现

  • 东南亚携带经典k13突变的虫株清除半衰期延长,且清除半衰期与RSA存活率高度一致。
  • 东非和非洲之角独立出现的k13突变虫株清除动力学更快,但RSA存活率升高。

关键数值与推荐

  • 现行青蒿素部分耐药监测定义依赖源自东南亚的恶性疟原虫清除半衰期阈值。
  • 东非和非洲之角独立出现的k13突变虫株清除动力学更快但RSA存活率升高,与东南亚模式不同。

临床怎么用

  • 非洲地区需采用整合清除半衰期、RSA、分子标记和伙伴药物敏感性的区域特异性监测标准。
  • 不宜直接套用东南亚清除半衰期阈值判读非洲青蒿素部分耐药,以免延迟政策响应。

局限性

  • 综述中仅35项研究提供基因型相关的清除半衰期或RSA数据,证据覆盖有限。
  • 清除表型差异可能反映宿主和流行病学背景的洲际差异,机制尚未完全明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Artemisinin-based combination therapies (ACTs) remain the cornerstone of global malaria treatment, yet their long-term efficacy is threatened by the emergence of artemisinin partial resistance (ART-R). Current surveillance definitions rely on Plasmodium falciparum parasite clearance half-life thresholds derived from southeast Asia, where mutant kelch13 (k13)-mediated resistance produces prolonged parasite clearance half-life values after ACT treatment. Whether these thresholds appropriately capture resistance phenotypes in Africa remains uncertain. We systematically reviewed 96 studies across southeast Asia and Africa, with 35 reporting genotype-linked parasite clearance half-life or ring-stage survival (RSA) data or both, to assess continental differences in clearance dynamics. In southeast Asia, parasites harbouring canonical k13 mutations consistently displayed prolonged parasite clearance half-life values compared with ART-sensitive infections, with a strong concordance between parasite clearance half-life and RSA survival. In east Africa and the Horn of Africa, however, independently emergent k13 mutations generally exhibited faster clearance kinetics despite elevated RSA survival rates. This discrepancy might reflect continental differences in host and epidemiological contexts and risks under-detecting emerging ART-R in Africa. Parasite clearance half-life thresholds, if unmodified, could continue to obscure early signals of spread and delay policy responses in African settings. Region-specific surveillance criteria integrating parasite clearance half-life, RSA, molecular markers, and partner-drug susceptibility are urgently needed to prevent resistant parasites from achieving genetic fixation, as earlier occurred in the Greater Mekong Subregion in Asia.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Hosangadi V, Fidock DA. Artemisinin partial resistance at a crossroads: evidence for continental variation in Plasmodium falciparum clearance phenotypes. Lancet Infect Dis. 2026. PMID: 42107390. doi:10.1016/S1473-3099(26)00132-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。